The agreement establishes Amazon AWS as Novo Nordisk's preferred cloud provider and strategic AI partner. The two companies have also established a joint innovation center in London, where AWS engineers and AI experts will work alongside Novo Nordisk's R&D teams to analyze scientific data, identify potential drug targets, and improve operational efficiency using services such as Amazon Bio Discovery and Amazon Bedrock.